Abbonarsi

Endoscopic papillary balloon dilation for the management of bile duct stones in patients 85 years of age and older - 23/08/11

Doi : 10.1016/j.gie.2007.10.066 
Yukiko Ito, MD, Takeshi Tsujino, MD , Osamu Togawa, MD, Natsuyo Yamamoto, MD, Hiroyuki Isayama, MD, Ryo Nakata, MD, Takao Kawabe, MD, Masao Omata, MD
Current affiliations: Department of Gastroenterology, Japanese Red Cross Medical Center (Y.I., T.T., R.N.), Department of Gastroenterology, Faculty of Medicine, University of Tokyo (T.T., O.T., H.I., M.O.), Department of Gastroenterology, International University of Health and Welfare, Mita Hospital (N.Y.), Department of Endoscopy and Endoscopic Surgery, Faculty of Medicine, University of Tokyo (T.K.), Tokyo, Japan 

Reprint requests: Takeshi Tsujino, MD, Department of Gastroenterology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan.

Tokyo, Japan

Abstract

Background

Endoscopic papillary balloon dilation (EPBD) is a possible alternative to endoscopic sphincterotomy for the treatment of bile duct stones. However, little information is available in the elderly.

Objective

Our purpose was to evaluate the safety and efficacy of EPBD for bile duct stones in patients of 85 years of age and older.

Design

Retrospective study from a single center.

Setting

Tertiary care facility with experience in bile duct stone removal with EPBD.

Patients

A total of 406 patients (74 patients ≥85 years old, group A; 332 patients <85 years old, group B) with bile duct stones underwent EPBD.

Main Outcome Measurements

Efficacy and safety of EPBD between the 2 groups. Baseline patient characteristics were also evaluated.

Results

The mean American Society of Anesthesiologists score in group A was significantly higher compared with that in group B (2.4 [0.5] vs 1.9 [0.7], P < .0001). Patients received anticoagulants more frequently and had larger and more numerous stones in group A than in group B with significant differences. Overall, bile duct clearance rates were similar in the 2 groups (91% vs 95%), but the mean number of sessions required for complete stone removal was significantly higher in group A (1.6 vs 1.4, P = .0081). The incidence of overall early complications after EPBD was lower in group A than in group B (2.7% vs 8.4%) but was not statistically different. None of the patients in group A had post-EPBD pancreatitis, whereas pancreatitis occurred in 5.7% in group B (P = .036). Bleeding was not observed after EPBD in 406 patients, including 7 patients in group A who received anticoagulation therapy at the time of EPBD. There was no significant difference in the cumulative stone nonrecurrence rate between group A and group B (log-rank test, P = .6225).

Conclusions

EPBD is a safe and effective technique for the treatment of bile duct stones even in high-risk elderly patients without an increased risk of pancreatitis and bleeding. Because the evaluation of outcomes might be biased by our study design (an open study), further studies are needed.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ASA, EML, EPBD, EST


Mappa


© 2008  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 68 - N° 3

P. 477-482 - settembre 2008 Ritorno al numero
Articolo precedente Articolo precedente
  • EUS accurately predicts the need for therapeutic ERCP in patients with a low probability of biliary obstruction
  • Jan Janssen, Ali Halboos, Lucas Greiner
| Articolo seguente Articolo seguente
  • Endoscopic balloon dilation of the sphincter of Oddi for stone extraction in the elderly: is the juice worth the squeeze?
  • James A. DiSario

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.